Advertisement
Advertisement
U.S. markets close in 3 hours 52 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Arch Therapeutics, Inc. (ARTH)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0400-0.0013 (-3.15%)
As of 11:43AM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0413
Open0.0420
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0400 - 0.0499
52 Week Range0.0101 - 0.1370
Volume30,860
Avg. Volume431,280
Market Cap9.995M
Beta (5Y Monthly)0.48
PE Ratio (TTM)N/A
EPS (TTM)-0.0240
Earnings DateDec 11, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for ARTH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • ARCH THERAPEUTICS INC
    Analyst Report: Baxter International Inc.Based in Deerfield, Illinois, Baxter International provides critical care, nutrition, renal, hospital, and surgical products. Baxter has approximately 60,000 employees and manufacturing operations in more than 20 countries. It is also a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
Advertisement
Advertisement